ACSL6 is phosphorylated at Ser674 by extracellular signal-regulated kinase 2 (ERK2), and this phosphorylation subsequently interacts with IL18R to modulate NF-κB gene expression, thereby promoting tumor progression [127]. The gene discussed is MAPK1; the disease is neoplasm.